PMC9131937_01
Treatment course of the patient (girl, 13 years old) including Rituximab, methylprednisolone, pyridostigmine, and intravenous immunogloblin (IVIG).
fped-10-788353-g0001.jpg
PMC9131937_01_fped-10-788353-g0001.jpg
F1
Antibodies related to MG, such as anti-AChR and anti-MuSK antibodies, became negative, and clinical remission was achieved (in Figure 1).